| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2008;117:2583-2590.)
© 2008 American Heart Association, Inc.
Arrhythmia/Electrophysiology |
From the Divisions of Cardiovascular Diseases (Y.-M.C., P.A.F., S.J.A., W.-K.S., T.M.M., R.F.R., P.A.B., A.J., K.H.M., B.J.G., S.C.H., D.L.P.) and Biostatistics (D.O.H., R.A.M.), Mayo Clinic, Rochester, Minn.
Reprint requests to Yong-Mei Cha, MD, Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905. E-mail ycha{at}mayo.edu
Received May 21, 2007; accepted March 10, 2008.
Background— Obesity is a risk factor for atrial fibrillation and other cardiovascular conditions. Our objective was to determine whether catheter-based ablation effectively treated atrial fibrillation in obese patients.
Methods and Results— Five hundred twenty-three consecutive patients with symptomatic, medication-refractory atrial fibrillation underwent catheter ablation. Patients were grouped by body mass index (lean, <25 kg/m2; overweight, 25 to 29.9 kg/m2; obese,
30 kg/m2). Outcome and quality of life were measured with a general health survey (Medical Outcomes Study 36-item Short-Form General Health Survey [SF-36]); patients were assessed before ablation and at 3 and 12 months after the procedure. Two hundred twenty-eight study patients (44%) were overweight, and 201 (38%) were obese. Twelve months after curative ablation, 72% of patients were free of atrial fibrillation without the use of antiarrhythmic agents; 84% were arrhythmia free when those receiving medication were included. Atrial fibrillation was eliminated in 75%, 72%, and 70% of the lean, overweight, and obese patients, respectively, at 12 months (P=0.41, trend test). SF-36 scores were lower for patients with higher body mass index (P<0.05) at baseline. SF-36 scores improved in every functional domain for all body mass index groups after ablation. The mean SF-36 total physical score increased from 59±20 at baseline to 77±19 in 12 months (P<0.001). The total mental health score improved from 66±18 to 79±16 in 12 months (P<0.001).
Conclusions— Catheter ablation of atrial fibrillation was effective in obese patients. Coexistence of atrial fibrillation and obesity indicated lower SF-36 scores, but the improvement in quality of life was consistent across all body mass index categories.
Related Article:
This article has been cited by other articles:
![]() |
C. Scharf, L. Boersma, W. Davies, P. Kanagaratnam, N. S. Peters, V. Paul, E. Rowland, A. Grace, S. Fynn, L. Dang, et al. Ablation of Persistent Atrial Fibrillation Using Multielectrode Catheters and Duty-Cycled Radiofrequency Energy J. Am. Coll. Cardiol., October 6, 2009; 54(15): 1450 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Terasawa, E. M. Balk, M. Chung, A. C. Garlitski, A. A. Alsheikh-Ali, J. Lau, and S. Ip Systematic Review: Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation Ann Intern Med, August 4, 2009; 151(3): 191 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chilukuri, D. Dalal, J. E. Marine, D. Scherr, C. A. Henrikson, A. Cheng, S. Nazarian, D. Spragg, R. Berger, and H. Calkins Predictive value of obstructive sleep apnoea assessed by the Berlin Questionnaire for outcomes after the catheter ablation of atrial fibrillation Europace, July 1, 2009; 11(7): 896 - 901. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |